1 asset in Grade III Prostatic Intraepithelial Neoplasia

Therapeutic assets addressing Grade III Prostatic Intraepithelial Neoplasia, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
9-valent human papillomavirus recombinant vaccine Grade III Prostatic Intraepithelial Neoplasia	Shanghai Bovax Biotechnology Co., Ltd.	P3	B (60)